Team helps cancer treatment drugs get past their sticking point
Wednesday, April 23, 2014 - 08:50
in Physics & Chemistry
Potentially valuable drugs slowed down by sticky molecules may get another shot at success. Joint research by the National Institute of Standards and Technology (NIST), Genentech, the University of Delaware and Institut Laue-Langevin (ILL) has revealed the reason why a certain class of proteins tends to form clusters that lead to high viscosity in drug solutions.